Filing Details
- Accession Number:
- 0001104659-22-128769
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-20 20:01:35
- Reporting Period:
- 2022-12-16
- Accepted Time:
- 2022-12-20 20:01:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1571934 | Synaptogenix Inc. | SNPX | Pharmaceutical Preparations (2834) | 461585656 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1619259 | Jonathan Schechter | C/O Synaptogenix, Inc., 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share | Disposition | 2022-12-16 | 20,250 | $1.17 | 28,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.